secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mineralys Therapeutics, Inc. (MLYS)
CIK:        0001933414
Form:       8-K
Filed at:   2024-05-22T23:59:59+00:00
Accession:  0001933414-24-000017
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Stockholders elect Jon Congleton as Class I director and ratify Ernst & Young as auditor at 2024 annual meeting
--------------------------------------------------------------------------------

- Proposal 1: Jon Congleton elected as Class I director with 26,418,385 votes for, 3,775,533 withheld, 1,838,014 broker non-votes.
- Proposal 2: Ratification of Ernst & Young as independent auditor approved with 32,025,366 for, 1,187 against, 5,379 abstain.
- Annual meeting held May 22, 2024; both proposals passed with requisite votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1933414/000193341424000017/0001933414-24-000017-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1933414/000193341424000017/mlys-20240522.htm
  HTML page:      https://secwatch.observer/filing/0001933414-24-000017

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer